- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05554055
Correlation Between LR-ACT and Anti Xa Activity During Endovascular Surgery Procedures. AXAES (Anti Xa vs ACT-LR in Endovascular Surgery) (AXAES)
Correlation Between LR-ACT and Anti Xa Activity During Endovascular Surgery Procedures.
Activated clotting time (ACT) is currently recommended to monitor high concentrations heparin anticoagulation. ACT-LR was specifically designed to measure the activity of low dose of heparin used during endovascular surgery. The correlation between ACT-LR and Anti Xa activity which is considered as the gold standard seems to be debated.
Few studies in literature had shown controversial results. These studies were conducted in patients who underwent open as endovascular surgery. However, the ACT monitoring is not recommended in open surgery. In addition, heparin administration protocols are not described and specific to each centre.
In this study investigators want to study the correlation between LR-ACT and anti Xa after introducing a heparin protocol during complex endovascular procedures.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Marine BORDET, Surgical Resident
- Phone Number: +33 0472117676
- Email: marine.bordet@chu-lyon.fr
Study Locations
-
-
-
Bron, France, 69500
- Service de chirurgie vasculaire (U50) Hôpital Louis Pradel - HCL
-
Contact:
- Marine BORDET, Surgical Resident
- Phone Number: +33 0472117676
- Email: marine.bordet@chu-lyon.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age ≥ 18 ans
- Weight ≥ 37,5 kg
- Patients operated for
- complex endovascular aortic aneurysm repair
- deep vein recanalization
- complex arterial revascularization (TASC D lesions)
- Patient informed of the study details and who didn't opposed to participate in this research
Exclusion Criteria:
- Known allergy to heparin
- Known hepatic insufficiency with repercussion on coagulation
- Thrombocytopenia
- Known hemostasis disorders
- Anemia defined HB<8 g/L
- Pregnant women
- Persons deprived of their liberty by a judicial or administrative decision
- Persons subject to psychiatric care
- Persons admitted to a health or social establishment for purposes other than research
- Adults subject to a legal protection measure (guardianship, curatorship)
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Correlation between ACT (second) realized in operative room and Anti Xa activity (UI/ml) results provide by the lab.
Time Frame: During surgery - 1 day
|
Following the heparin administration protocol, each ACT measurement will be associated to a blood samples for anti Xa activity measurement. Retrospectively, anti Xa results will be analyze and compare to ACT value which will be report in the operative report. The blood samples will be taken in operative room during endovascular procedures as defined in the protocol. |
During surgery - 1 day
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (ANTICIPATED)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 69HCL22_0104
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Thrombosis
-
Università degli Studi dell'InsubriaOttawa Hospital Research InstituteUnknownPortal Vein Thrombosis | Mesenteric Vein Thrombosis | Splenic Vein ThrombosisCanada, Italy
-
University of MaltaUniversità degli Studi dell'InsubriaRecruitingCerebral Vein Thrombosis | Renal Vein Thrombosis | Retinal Vein Thrombosis | Splanchnic Vein Thrombosis | Ovarian Vein ThrombosisThailand, Spain, United States, Italy, Slovenia, France, Israel, Canada, Malta, Netherlands
-
Capital Medical UniversityBeijing Municipal Science & Technology CommissionNot yet recruitingCerebral Venous Sinus Thrombosis | Deep Cerebral Vein Thrombosis | Cortical Vein Thrombosis
-
University of AlbertaSanofi; Edmonton Civic Employees Research FundTerminatedPortal Vein Thrombosis | Splenic Vein ThrombosisCanada
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)CompletedDeep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism | Malignant Neoplasm | Portal Vein Thrombosis | Metastatic Malignant Neoplasm | Cerebral Vein Thrombosis | Renal Vein Thrombosis | Gonadal Thrombosis | Hepatic Thrombosis | Mesenteric Thrombosis | Splenic ThrombosisUnited States
-
Assiut UniversityNot yet recruitingPortal Vein Thrombosis
-
Azienda Ospedaliera Universitaria PoliclinicoCompletedDeep Vein ThrombosisItaly
-
University of OklahomaPfizerCompleted
-
Fondazione Policlinico Universitario Agostino Gemelli...RecruitingSplanchnic Vein ThrombosisItaly
-
University Hospital, GenevaSunnybrook Health Sciences CentreNot yet recruitingDeep Vein Thrombosis
Clinical Trials on Anti Xa activity measurement.
-
University of Eastern FinlandCompletedQuality of Life | Fatigue | Physical Activity | Relapsing Remitting Multiple SclerosisFinland
-
Marmara UniversityUnknown
-
University Hospital, MontpellierUnknownRestless Legs Syndrome | Willis-Ekbom DiseaseFrance
-
Seoul National University HospitalCompletedWomen Who Underwent Midline Incision, Gynecological SurgeryKorea, Republic of
-
Marius HenriksenCompletedPulmonary Disease | Cardiac Disease | Geriatric DiseaseDenmark
-
Bassett HealthcareCompletedEarly Mobilization of Mechanically Ventilated PatientsUnited States
-
University of PennsylvaniaBaylor College of Medicine; Columbia UniversityEnrolling by invitation
-
Centre Hospitalier Universitaire de NīmesRecruiting
-
Czech Technical University in PragueRecruitingBlood Pressure | Heart RateCzechia
-
University of Southern CaliforniaNational Cancer Institute (NCI)Active, not recruitingSolid NeoplasmUnited States